PI(4)K Inhibitor Could Prove Cure For Killer Diarrhoea

News   Jun 06, 2017 | Original Story from Novartis

 
A Cryptosporidium PI(4)K Inhibitor is a Drug Candidate for Cryptosporidiosis

Cryptosporidium parvum. Credit: EPA/H.D.A. Lindquist

 
 
 
 

RELATED ARTICLES

Easily Automate PK Assays for Human IgG Drugs in Preclinical Species

News

At AAPS NBC event, Lumigen produced a poster summarizing the use of their pipetting robot, Andrew which can measure IgG drug concentration in a pre-clinical setting.

READ MORE

Could This Be a "Silver Bullet" for Preventing and Treating Colon Cancer?

News

A team of scientists targeted the gene CtBP with a drug known as HIPP (2-hydroxy-imino phenylpyruvic acid) and were able to reduce the development of pre-cancerous polyps by half.

READ MORE

A Rogue Gene is Causing Seizures in Babies. Here’s How MSU Wants to Stop it

News

The researchers are closer to understanding the source of the seizures, a gene known as GNAO1 and the transformations it can take on, and potentially stopping its devastating effects by uncovering key differences in the way it functions.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE